|A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity|
CG Vinuesa, MC Cook, C Angelucci, V Athanasopoulos, L Rui, KM Hill, ...
Nature 435 (7041), 452-458, 2005
|MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers|
C Steidl, SP Shah, BW Woolcock, L Rui, M Kawahara, P Farinha, ...
Nature 471 (7338), 377-381, 2011
|Cooperative epigenetic modulation by cancer amplicon genes|
L Rui, NCT Emre, MJ Kruhlak, HJ Chung, C Steidl, G Slack, GW Wright, ...
Cancer cell 18 (6), 590-605, 2010
|Resistance to CpG DNA–induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling|
L Rui, CG Vinuesa, J Blasioli, CC Goodnow
Nature immunology 4 (6), 594-600, 2003
|Malignant pirates of the immune system|
L Rui, R Schmitz, M Ceribelli, LM Staudt
Nature immunology 12 (10), 933-940, 2011
|Selective interleukin-1 receptor–associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy|
PN Kelly, DL Romero, Y Yang, AL Shaffer III, D Chaudhary, S Robinson, ...
Journal of Experimental Medicine 212 (13), 2189-2201, 2015
|ERK signaling is a molecular switch integrating opposing inputs from B cell receptor and T cell cytokines to control TLR4-driven plasma cell differentiation|
L Rui, JI Healy, J Blasioli, CC Goodnow
The Journal of Immunology 177 (8), 5337-5346, 2006
|Novel properties of the nucleolar targeting signal of human angiogenin|
R Lixin, A Efthymiadis, B Henderson, DA Jans
Biochemical and biophysical research communications 284 (1), 185-193, 2001
|Inhibition of nuclear import mediated by the Rev-arginine rich motif by RNA molecules|
K Fineberg, T Fineberg, A Graessmann, NW Luedtke, Y Tor, R Lixin, ...
Biochemistry 42 (9), 2625-2633, 2003
|A mutation in a chromosome condensin II subunit, kleisin β, specifically disrupts T cell development|
KM Gosling, LE Makaroff, A Theodoratos, YH Kim, B Whittle, L Rui, H Wu, ...
Proceedings of the National Academy of Sciences 104 (30), 12445-12450, 2007
|Lymphoma and the control of B cell growth and differentiation|
L Rui, CC Goodnow
Current molecular medicine 6 (3), 291-308, 2006
|Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma|
L Lu, F Zhu, M Zhang, Y Li, AC Drennan, S Kimpara, I Rumball, C Selzer, ...
Proceedings of the National Academy of Sciences 115 (3), E498-E505, 2018
|Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma|
M Chiorazzi, L Rui, Y Yang, M Ceribelli, N Tishbi, CW Maurer, ...
Proceedings of the National Academy of Sciences 110 (10), 3943-3948, 2013
|FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma|
Y Li, MN Bouchlaka, J Wolff, KM Grindle, L Lu, S Qian, X Zhong, N Pflum, ...
Oncogene 35 (48), 6223-6234, 2016
|Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma|
L Rui, AC Drennan, M Ceribelli, F Zhu, GW Wright, W Xiao, Y Li, ...
Proceedings of the National Academy of Sciences 113 (46), E7260-E7267, 2016
|Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2|
DJ Hodson, AL Shaffer, W Xiao, GW Wright, R Schmitz, JD Phelan, ...
Proceedings of the National Academy of Sciences 113 (14), E2039-E2046, 2016
|Withaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-κB signaling|
SS Jackson, C Oberley, CP Hooper, K Grindle, S Wuerzberger-Davis, ...
Experimental cell research 331 (1), 58-72, 2015
|Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-κB activity and increases drug resistance in multiple myeloma|
M Huynh, C Pak, S Markovina, NS Callander, KS Chng, ...
Journal of Biological Chemistry 293 (7), 2452-2465, 2018
|PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells|
F Zhu, H Guo, PD Bates, S Zhang, H Zhang, KJ Nomie, Y Li, L Lu, ...
Leukemia 33 (12), 2898-2911, 2019
|STAT3 activation and oncogenesis in lymphoma|
F Zhu, KB Wang, L Rui
Cancers 12 (1), 19, 2020